Hosted on MSN

Artivion’s aortic stents boost post-surgical outcomes in interventional studies

Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended benefits to patients. This includes one-year data from the ...
Business Wire

Endospan Announces Positive 30-Day Data from TRIOMPHE FDA Clinical Study of NEXUS® Aortic Arch Stent-Graft

TEL AVIV, Israel--(BUSINESS WIRE)--Endospan today announced the presentation of 30-day results of the statistical Dissection Primary Arm from the TRIOMPHE Investigational Device Exemption (IDE) ...
Business Wire

Endospan Announces Positive One-Year Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System

TEL AVIV, Israel--(BUSINESS WIRE)--Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE ...
MarketWatch

Endospan Receives FDA Approval for the NEXUS(R) Aortic Arch Stent Graft System

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS(R) ...
Medscape

Innovative New Procedure May Change the Future of Some Coronary Artery Bypass Surgeries

Imagine a patient in their late sixties who has been living with a bioprosthetic aortic valve when, due to calcium buildup, the valve begins to fail and must be replaced. Because of the patient’s ...
Baylor College of Medicine

Center for Aortic Surgery

At the Baylor Medicine Center for Aortic Surgery in Houston, we are one of the nation’s leading centers for the treatment of complex aortic diseases. We offer comprehensive care for aortic aneurysms, ...